
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Epidemiology Biomarkers & Prevention, Vol 4, Issue 7 727-733, Copyright © 1995 by American Association for Cancer Research
ARTICLES |
NF Boyd, P Connelly, J Byng, M Yaffe, H Draper, L Little, D Jones, LJ Martin, G Lockwood and D Tritchler
Division of Epidemiology and Statistics, Ontario Cancer Institute, Toronto, Canada.
There is strong evidence that the risk of breast cancer in populations is influenced by environmental factors. Plasma lipids and lipoproteins are known to be under environmental control and to have epidemiological and/or biological characteristics that suggest they may be relevant to breast cancer risk. The purpose of the study described here was to determine whether plasma lipids, lipoproteins, and the urinary excretion of the mutagen malondialdehyde (MDA) are associated with differences in breast cancer risk. We measured plasma lipids, lipoproteins, and urinary MDA in women without breast cancer but with different degrees of density of the breast parenchyma on mammography, a strong risk factor for breast cancer. Mammograms from 273 premenopausal women were digitized to high spatial resolution by a scanning densitometer, and images were analyzed to quantify the extent of density. The percentage of the breast occupied by mammographic densities was found, after controlling for the effects of age and the Quetelet index of obesity, to be significantly associated with plasma levels of high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglyceride, apoprotein B, and urinary excretion of MDA. A multivariate model comprised of the Quetelet index of obesity, alcohol consumption, apoprotein B, parity, daily MDA excretion, and the skinfold thickness sum accounted for 36% of the variation in breast density. These results suggest that differences in lipid metabolism are associated with differences in breast cancer risk as defined by mammographic densities. These findings are consistent with several other observations that show a relationship between plasma lipids, lipoproteins, and risk factors for breast cancer.
This article has been cited by other articles:
![]() |
C M Friedenreich and A E Cust Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects Br. J. Sports Med., August 1, 2008; 42(8): 636 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Boudreau, C. M. Rutter, and D. S.M. Buist The influence of statin use on breast density. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 1026 - 1029. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Gapstur, P. Lopez, L. A. Colangelo, J. Wolfman, L. Van Horn, and R. E. Hendrick Associations of Breast Cancer Risk Factors with Breast Density in Hispanic Women Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 1074 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Hong, H. J. Thompson, C. Jiang, G. L. Hammond, D. Tritchler, M. Yaffe, and N. F. Boyd Val158Met Polymorphism in Catechol-O-methyltransferase Gene Associated with Risk Factors for Breast Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 838 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Jakes, S. W. Duffy, F.-C. Ng, F. Gao, E.-H. Ng, A. Seow, H.-P. Lee, and M. C. Yu Mammographic Parenchymal Patterns and Self-reported Soy Intake in Singapore Chinese Women Cancer Epidemiol. Biomarkers Prev., July 1, 2002; 11(7): 608 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Singletary and S. M. Gapstur Alcohol and Breast Cancer: Review of Epidemiologic and Experimental Evidence and Potential Mechanisms JAMA, November 7, 2001; 286(17): 2143 - 2151. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Maskarinec, L. Meng, and G. Ursin Ethnic differences in mammographic densities Int. J. Epidemiol., October 1, 2001; 30(5): 959 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Vachon, L. H. Kushi, J. R. Cerhan, C. C. Kuni, and T. A. Sellers Association of Diet and Mammographic Breast Density in the Minnesota Breast Cancer Family Cohort Cancer Epidemiol. Biomarkers Prev., February 1, 2000; 9(2): 151 - 160. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |